QuidelOrtho Files 8-K on Financials
Ticker: QDEL · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1906324
| Field | Detail |
|---|---|
| Company | Quidelortho Corp (QDEL) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, exhibits
Related Tickers: QDEL
TL;DR
QDEL filed an 8-K on Jan 13, 2025, detailing financial condition and results. Check it for performance updates.
AI Summary
QuidelOrtho Corp. filed an 8-K on January 13, 2025, reporting on its Results of Operations and Financial Condition, and including Financial Statements and Exhibits. The filing details information related to the company's financial performance and condition as of January 13, 2025. QuidelOrtho Corp. was formerly known as Coronado Topco, Inc. before a name change on January 24, 2022.
Why It Matters
This 8-K filing provides investors with crucial updates on QuidelOrtho's financial health and operational results, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not appear to contain any unusual or high-risk events.
Key Players & Entities
- QuidelOrtho Corp. (company) — Registrant
- Coronado Topco, Inc. (company) — Former company name
- January 13, 2025 (date) — Date of report
- January 24, 2022 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on QuidelOrtho Corp.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is January 13, 2025.
What was QuidelOrtho Corp.'s former name?
QuidelOrtho Corp.'s former name was Coronado Topco, Inc.
When did the company's name change from Coronado Topco, Inc. to QuidelOrtho Corp.?
The date of the name change was January 24, 2022.
What is the principal executive office address for QuidelOrtho Corp.?
The principal executive office address is 9975 Summers Ridge Road, San Diego, California 92121.
Filing Stats: 787 words · 3 min read · ~3 pages · Grade level 13.7 · Accepted 2025-01-13 09:03:17
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 Par Value QDEL The Nasdaq Stock Market
Filing Documents
- qdel-20250113.htm (8-K) — 32KB
- qdel011320258-kitem991.htm (EX-99.1) — 16KB
- qologoa.jpg (GRAPHIC) — 12KB
- 0001906324-25-000003.txt ( ) — 220KB
- qdel-20250113.xsd (EX-101.SCH) — 2KB
- qdel-20250113_def.xml (EX-101.DEF) — 14KB
- qdel-20250113_lab.xml (EX-101.LAB) — 25KB
- qdel-20250113_pre.xml (EX-101.PRE) — 15KB
- qdel-20250113_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 13, 2025, QuidelOrtho Corporation ("QuidelOrtho") issued a press release announcing its preliminary unaudited revenue results for its fourth quarter ended December 29, 2024. A copy of the press release is furnished with this Current Report on Form 8-K ("Form 8-K") as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished with this Form 8-K: Exhibit Number Description of Exhibit 99.1 Press Release issued by QuidelOrtho Corporation dated January 13 , 202 5 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL Document. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This financial information set forth in this Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly historical, including, but not limited to, QuidelOrtho's preliminary unaudited revenues for the fourth quarter ended December 29, 2024, and other preliminary estimates or future financial condition and operating results, and other plans, objectives, strategies, expectations and intentions. The preliminary financial information for the fourth quarter ended December 29, 2024, set forth in this Form 8-K represents preliminary and unaudited estimates, and such estimates are inherently uncertain and subject to change as QuidelOrtho completes the preparation of its consolidated financial statements and related notes and completes its financial close procedures for the year ended December 29, 2024. Final financial results may therefore vary from the estimates set forth in this 8-K, and such variations to the preliminary unaudited estimates may be material. You should not rely on forward-looking statements as predictions of future events because these estimates are based on assumptions that may not come true and are speculative by their nature. All forward-looking statements are based on information currently available to QuidelOrtho and speak only as of the date hereof. QuidelOrtho undertakes no obligation to update any of the forward-looking information or time-sensitive information included in this Form 8-K, whether as a result of
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 QUIDELORTHO CORPORATION By: /s/ Joseph M. Busky Name: Joseph M. Busky Its: Chief Financial Officer